Home › Forums › Decaffeinated Coffee › Yale hydroxy › Reply To: Yale hydroxy
“The untreated group was “unhealthier” because they were not being treated.”
Maybe.
LEts focus on one arm of the study starting with Group those over 60 years of age.
However how many of the study cohort had COPD?
Have a look (the easiest place to see is Table 2)
How many of the control goup had COPD?
This is harder becasue we don’t know. In the general population over 60 its about 10%
That is a big difference!
“We can’t say that age in itself is an influencing factor”
Why not?
A lot of data skews that way. And it was one of the assumptions of the entire study. Remember Dr Zelnkos says not to give everybody. Just those older (over 60 group A in the study) shortness of breath (group B) and sicker (group C) . It is odd that Dr,. Zelenko beelives age is a factor but you are trying to defend his study by saying it isnt
“but in the end, it is all up to Hashem as He Alone is in control.”
Sure so forget this conversation. ou dont care about studies, you dont need HCQ Hashem is in control. finished.
“So the treatment was effective.”
Could be. But Dr. Zelnko’s study doesnt show that